InvestorsHub Logo
Followers 234
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: lizzy241 post# 286592

Thursday, 07/16/2020 5:37:04 PM

Thursday, July 16, 2020 5:37:04 PM

Post# of 426307
Thanks very helpful. Hikma helped spark opioid epidemic & now are totally fine taking out a future drug candidates for the big 3, Alzheimer’s, NASH and cancer....

Hikma Pharmaceuticals is leading the FTSE 250 this morning, up 7.5% at £20.62, after it lifted its sales forecast as it supplies more opioid painkillers to the US which is experiencing a shortage.

Its full-year outlook has been boosted by both its injectables division and its generic drugs business.



BB

If you're not good at being yourself, then maybe that's being yourself!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News